About Wuhan Healthgen Biotechnology Corp.
Wuhan Healthgen Biotechnology Corp., known by its Oryzogen brand, is a biotechnology company founded in 2006 at the BioLake biological industry base in Wuhan, Hubei province. Its distinctive trait is the use of rice endosperm as a plant bioreactor to express human proteins, a proprietary platform combining biotechnology, modern agriculture and biopharmaceutical production within a single industrial model.
Its core product is recombinant human serum albumin obtained from rice, designed as a safe and consistent alternative to plasma-derived albumin, together with growth factors and other recombinant proteins. Those proteins are used as cell-culture media supplements, cosmetic additives and industrial biological reagents for biopharmaceutical manufacturing and life-science research.
In the biotechnology and laboratory category, Healthgen represents the convergence of plant and laboratory: it turns an agricultural crop, rice, into a factory for high-value molecules. Its recent regulatory track record in China, with the approval of its injectable recombinant albumin, strengthens its position as a global reference for plant-derived recombinant proteins.
Its core product is recombinant human serum albumin obtained from rice, designed as a safe and consistent alternative to plasma-derived albumin, together with growth factors and other recombinant proteins. Those proteins are used as cell-culture media supplements, cosmetic additives and industrial biological reagents for biopharmaceutical manufacturing and life-science research.
In the biotechnology and laboratory category, Healthgen represents the convergence of plant and laboratory: it turns an agricultural crop, rice, into a factory for high-value molecules. Its recent regulatory track record in China, with the approval of its injectable recombinant albumin, strengthens its position as a global reference for plant-derived recombinant proteins.